Clarify Health unveils cloud software to improve clinical trial diversity
The analytics of the software is based on a dataset that comprises SDoH data at the patient level for a…
Clinical Trials
Latest in
Clinical Trials
Panbela begins Phase II pancreatic ductal adenocarcinoma trial
Screening for eligible subjects for the trial has started and enrolment is anticipated to conclude in nearly one year.
The increasing trend towards allogeneic cell therapy
As of January 17, 2022, GlobalData noted 542 active chimeric antigen receptor (CAR) T-cell (CAR-T cell) agents in the global…
By
Moderna doses first subject in Phase II booster vaccine trial
The trial is expected to enrol approximately 300 subjects to receive a single dose of mRNA-1273.529 booster.
Vutrisiran HELIOS-A results bolster its FDA application
According to Alnylam's HELIOS-A study, vutrisiran met all secondary endpoints for ATTR neuropathy, which will boost its presence in the…
By
Pfizer, BioNTech start trial of Omicron-based Covid-19 vaccine
The trial will assess the tolerability, safety and immunogenicity of the vaccine in up to 1,420 subjects.
Ranok gets FDA clearance for Phase I/II cancer trial
Subject enrolment in the CHAMP-1 trial is expected to begin in the first half of this year.
Long Covid-19: drug trial results to watch in 2022
At least four long Covid-19 drug trial readouts are expected in 2022 that could shape the future of the therapeutic…
By